KING CROSS PRACTICE — All Prescriptions & Medications — Page 2
Practice Code: B84021 | HALIFAX, HX1 3LW
Showing results 51-100 of 579
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Zopiclone | 889 | 12.1K | £549 | +60.5% ▲ |
| Ezetimibe | 883 | 29.8K | £5.2K | +24.1% ▲ |
| Carbocisteine | 872 | 67.6K | £1.9K | +63.3% ▲ |
| Glucose blood testing reagents | 866 | 85.2K | £12.6K | +9.7% ▲ |
| Thiamine hydrochloride | 863 | 33.3K | £912 | +63.7% ▲ |
| Morphine sulfate | 862 | 76.9K | £2.7K | +31.5% ▲ |
| Duloxetine hydrochloride | 850 | 21.3K | £2.1K | +33.7% ▲ |
| Alendronic acid | 846 | 4,144 | £1.4K | +12.8% ▲ |
| Isosorbide mononitrate | 836 | 21.6K | £2.2K | +26.5% ▲ |
| Olanzapine | 827 | 11.3K | £3.0K | +123.2% ▲ |
| Empagliflozin | 824 | 19.1K | £23.7K | +31.7% ▲ |
| Hydrocortisone | 823 | 28.1K | £4.7K | +83.5% ▲ |
| Indapamide | 818 | 38.4K | £1.4K | -5.2% ▼ |
| Donepezil hydrochloride | 799 | 9,822 | £1.5K | +158.9% ▲ |
| Finasteride | 798 | 17.2K | £660 | +21.9% ▲ |
| Rosuvastatin calcium | 787 | 31.4K | £1.1K | -12.3% ▼ |
| Memantine hydrochloride | 779 | 12.0K | £4.1K | +135.8% ▲ |
| Bendroflumethiazide | 761 | 29.1K | £491 | -1.6% vs avg |
| Fexofenadine hydrochloride | 717 | 30.6K | £1.4K | -15.7% ▼ |
| Senna | 680 | 33.6K | £898 | +13.0% ▲ |
| Digoxin | 680 | 12.2K | £934 | +79.7% ▲ |
| Candesartan cilexetil | 677 | 14.8K | £723 | -42.9% ▼ |
| Venlafaxine | 672 | 13.6K | £2.8K | -20.5% ▼ |
| Alogliptin | 651 | 15.0K | £13.6K | +156.7% ▲ |
| Ferrous fumarate | 627 | 37.1K | £1.1K | -13.5% ▼ |
| Sacubitril/valsartan | 621 | 18.3K | £30.0K | +159.3% ▲ |
| Ibuprofen | 619 | 64.9K | £2.4K | +21.7% ▲ |
| Spironolactone | 609 | 11.6K | £3.2K | +13.0% ▲ |
| Cetirizine hydrochloride | 598 | 19.5K | £763 | +19.7% ▲ |
| Diazepam | 584 | 10.5K | £264 | +17.3% ▲ |
| Doxycycline hyclate | 580 | 7,529 | £754 | +13.1% ▲ |
| Sildenafil (Erectile Dysfunction) | 577 | 4,784 | £663 | +14.5% ▲ |
| Risperidone | 556 | 11.5K | £2.1K | +119.8% ▲ |
| Linagliptin | 556 | 11.3K | £12.8K | +35.7% ▲ |
| Gliclazide | 547 | 27.8K | £824 | -35.7% ▼ |
| Sodium valproate | 545 | 52.8K | £5.9K | +71.3% ▲ |
| Nitrofurantoin | 530 | 7,014 | £3.8K | +11.1% ▲ |
| Warfarin sodium | 529 | 24.2K | £842 | +12.2% ▲ |
| 520 | 1,085 | £36.1K | -4.6% ▼ | |
| Fluticasone propionate (Inhalation) | 505 | 768 | £16.3K | +30.5% ▲ |
| Alginic acid compound preparations | 496 | 278.8K | £3.4K | -15.3% ▼ |
| Co-beneldopa (Benserazide/levodopa) | 488 | 55.4K | £3.6K | +222.8% ▲ |
| Famotidine | 475 | 15.1K | £8.2K | -2.6% ▼ |
| Buprenorphine | 475 | 3,168 | £4.5K | +29.7% ▲ |
| Glimepiride | 473 | 17.9K | £542 | +412.6% ▲ |
| Mebeverine hydrochloride | 463 | 21.5K | £845 | +49.1% ▲ |
| Hydroxocobalamin | 461 | 598 | £1.3K | -4.2% ▼ |
| Docusate sodium | 457 | 20.7K | £1.5K | +23.3% ▲ |
| Oxycodone hydrochloride | 456 | 35.5K | £3.8K | +78.2% ▲ |
| Trazodone hydrochloride | 451 | 14.4K | £841 | +120.7% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.